Singer, Barry A. http://orcid.org/0000-0001-6875-7374
Feng, Jenny http://orcid.org/0000-0003-3700-7823
Chiong-Rivero, Horacio http://orcid.org/0000-0001-5233-7754
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 19 December 2023
Revised: 4 March 2024
Accepted: 4 March 2024
First Online: 14 April 2024
Declarations
:
: BS has received research grant support from AbbVie, Biogen, Bristol Myers Squibb, Greenwich Biosciences, Novartis, Sanofi, and TG Therapeutics and consulting and/or speaking fees from Alexion, Biogen, Bristol Myers Squibb, Cionic, Cycle, EMD Serono, Genentech, Horizon, Janssen, Novartis, Octave Bioscience, Roche, Sanofi, Sandoz, and TG Therapeutics. JF has served on advisory boards for Bristol Myers Squibb, Genentech, Horizon, Novartis, and TG Therapeutics. HCR is a paid speaker for Biogen and Janssen, has served on advisory board for Genentech, and has received fellowship grant support from the National MS Society.